Literature DB >> 16009754

Insulin resistance and cognitive impairment: a view through the prism of epidemiology.

Suzanne Craft.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16009754     DOI： 10.1001/archneur.62.7.1043-a

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  14 in total

Review 1.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

Review 2.  Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

Authors:  S M De La Monte
Journal:  Panminerva Med       Date:  2012-09       Impact factor: 5.197

Review 3.  Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed.

Authors:  Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

Review 5.  Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.

Authors:  Suzanne M de la Monte
Journal:  Eur Neuropsychopharmacol       Date:  2014-06-28       Impact factor: 4.600

6.  Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes.

Authors:  Hui Zhang; Ying Hao; Bradley Manor; Peter Novak; William Milberg; Jue Zhang; Jing Fang; Vera Novak
Journal:  Diabetes       Date:  2014-09-23       Impact factor: 9.461

7.  High-fat diet transition reduces brain DHA levels associated with altered brain plasticity and behaviour.

Authors:  Sandeep Sharma; Yumei Zhuang; Fernando Gomez-Pinilla
Journal:  Sci Rep       Date:  2012-05-30       Impact factor: 4.379

Review 8.  Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

Review 9.  Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

10.  Low fasting serum insulin and dementia in nondiabetic women followed for 34 years.

Authors:  Kirsten Mehlig; Leif Lapidus; Dag S Thelle; Margda Waern; Henrik Zetterberg; Cecilia Björkelund; Ingmar Skoog; Lauren Lissner
Journal:  Neurology       Date:  2018-07-11       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.